US Patent 6906069 LXR modulators
Patent 6906069 was granted and assigned to Amgen on June, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 30 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Oct, 2023
Golden AI
Edits made to:
Infobox (+12 properties)
Article (+429 characters)
Article
Patent abstract
The invention provides compounds, compositions and methods for modulating the effects of LXRα in a cell. The compounds and compositions are useful both as diagnostic indicators of LXRα function and as pharmacologically active agents. The compounds and compositions find particular use in the treatment of disease states associated with cholesterol metabolism, particularly atherosclerosis and hypercholesterolemia.
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Bei Shan0
Julio C. Medina0
Leping Li0
Date of Patent
June 14, 2005
0Patent Application Number
094793150
Date Filed
January 6, 2000
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6906069 LXR modulators
Find more entities like US Patent 6906069 LXR modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.